ANDA 77471, held by Genus Lifesciences. Hydromorphone Hydrochloride.
As of Nov 18, 2026, ANDA 77471 (Hydromorphone Hydrochloride), held by Genus Lifesciences, was first approved by FDA on Dec 9, 2009, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 9, 2009 | Original application | Approved |
| Hydromorphone Hydrochloride8MG · tablet;oral | Hydromorphone Hydrochloride | Discontinued |
| Hydromorphone Hydrochloride2MG · tablet;oral | Hydromorphone Hydrochloride | Discontinued |
| Hydromorphone Hydrochloride4MG · tablet;oral | Hydromorphone Hydrochloride | Discontinued |
| Oct 30, 2026 | Supplement 18Labeling · Standard review | Approved | None posted |
| Oct 30, 2026 | Supplement 21Labeling · Standard review | Approved | None posted |
| Oct 30, 2026 | Supplement 22Labeling · Standard review | Approved | None posted |
| Jun 18, 2026 | Supplement 23REMS | Approved | None posted |
| Nov 19, 2024 | Supplement 20REMS | Approved | None posted |
| Mar 12, 2020 | Supplement 9Labeling · Standard review | Approved | None posted |
| Mar 12, 2020 | Supplement 13Labeling · Standard review | Approved | None posted |
| Mar 12, 2020 | Supplement 16Labeling · Standard review | Approved | None posted |
| Sep 18, 2018 | Supplement 12REMS | Approved | None posted |
| Dec 9, 2009 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters